XML 51 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Derivative Instruments (Tables)
 12 Months Ended
Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments Measured at Fair Value

Derivative instruments measured at fair value and their classification on the consolidated balance sheets are presented in the following tables (in thousands):

 

     Liability as of December 31,  
     2014      2013  
     Notional
Amount		      Fair Value      Notional
Amount		      Fair Value  

Foreign exchange forward contract derivatives in cash flow hedging relationships - included in accrued and other current liabilities

    $ 25,990       $ (1,002 )     $ —         $ —     
Gains (Losses) on Derivative Instruments and Classification on Consolidated Statement of Operations

Gains (losses) on derivative instruments accounted for as hedges and their classification on the consolidated statement of operations, are presented in the following tables (in thousands):

 

     Years Ended December 31,  
     2014      2013      2012  

Foreign Exchange Forward Contract Derivatives in cash flow hedging relationships:

         

Gains recognized in OCI (a)

    $ 191       $ 730       $ 1,304   

Losses recognized in OCI (a)

    $ (1,846 )     $ (18 )     $ (225 ) 

Gains recognized from accumulated OCI into net loss (b)

    $ 55       $ 1,829       $ —     

Losses recognized from accumulated OCI into net loss (b)

    $ (708 )     $ —         $ (598 ) 

Losses recognized in net loss (c)

    $ —         $ —         $ (5 ) 

Foreign Exchange Forward Contract Derivatives not designated as hedging relationships:

         

Gains recognized in net loss (d)

    $ —         $ 71       $ 181   

Losses recognized in net loss (d)

    $ —         $ (60 )     $ (121 ) 

 

(a) Net change in the fair value of the effective portion classified in other comprehensive income (loss) (“OCI”).
(b) Effective portion of cash flow hedges reclassified from accumulated other income (loss), into net loss, of which $(72), $117 and $(45) were recognized within cost of sales for the years ended December 31, 2014, 2013 and 2012, respectively, and $(581), $1,712, and $(553) were recognized within operating expenses for the year ended December 31, 2014, 2013 and 2012, respectively. All amounts are reflected with the respective consolidated statement of operations.
(c) Ineffective portion and amount excluded from effectiveness testing classified in other income (expense), net.
(d) Classified in other income (expense), net.